Medication Assisted Treatment
Medication Assisted Treatment (MAT) is defined as the use of FDA- approved medications in combination with counseling and behavioral therapies, to provide a “whole-patient” approach to the treatment of substance use disorders. Research demonstrates a dramatic increase in efficacy of treatment and long term sustainable success when MAT is properly integrated into treatment. We specialize in all FDA approved Medication Assisted Treatment protocols including: Sublocade Injections (Monthly Buprenorphine Injections),
Suboxone, Probuphine Implants, Vivitrol, Chantix and Nicotine Replacement. We also provide Ketamine Infusions for both Chronic Pain and Severe Depression. Additionally, we provide a full range of psychopharmacological treatment options for both addiction and co-occurring psychiatric disorders.
In February 2018, SAMHSA published new treatment improvement protocols focusing on the utilization of medicated assisted treatment (MAT). HHS Secretary Alex Azar III publicly touted MAT as a crucial component of stemming the crisis. Azar went on to say, “Medication-assisted treatment works,” “The evidence on this is voluminous and ever growing.” By referencing that only about one-third of speciality substance abuse treatment programs offer MAT, Secretary Azar said that failing to do so, “is like trying to treat an infection without antibiotics.
For decades, Ketamine has been used “off-label” to treat chronic pain, depression and PTSD. Recent studies * have demonstrated Ketamine’s ability to rapidly and completely reverse suicidal depression in treatment-refractory patients. No other treatment modality has demonstrated such a rapid and profound response since electroconvulsive therapy (ECT). In fact, Thomas Insel, former Director, National Institute of Mental Health (NIMH) stated that “Recent data suggest that ketamine, given intravenously, might be the most important breakthrough in antidepressant treatment in decades.” However, unlike ECT, treatment with Ketamine infusions do not require an inpatient hospital stay, and the side effect profile is more favorable then ECT which can cause memory loss. Many severely depressed patients improve significantly in a matter of hours post treatment, however, multiple rounds of infusions are usually required for a sustained response. Current research is focusing on the use of Ketamine as a treatment for those suffering with chronic pain, addiction, PTSD, and other psychiatric disorders. Our doctors remain on the front lines of the technological advancements and research regarding both the utilization of Ketamine and the effective interactions with other medications such as Botox and CGRP inhibitors for significantly improved responses. Ketamine is a good alternative to patients who are medically addicted to painkillers and want to get off of them but need effective treatment for their chronic pain condition.
For more information on Ketamine and related articles check out the articles below:
- Burst Firing Sets The Stage For Depression
- Getting the Inside Dope on Ketamine’s Mysterious Ability to Rapidly Relieve Depression
- Ketamine for Depression: A Q&A with Psychiatrist Alexander Papp, MD
An FDA approved anti-addiction medication which blocks the opioid receptor in the brain, has proven to be a key clinical tool in the fight against both Opiate Addiction and Alcoholism. READ MORE >>
Blocks the effects of opioid medication, including pain relief or feelings of well-being that can lead to opioid abuse. The overall goal of treatment is to end the abuse of opioids. READ MORE>>
Is an implant that delivers a constant dose of buprenorphine to people living with opioid use disorders, they last six months following a single treatment procedure.